1. Optical Spectroscopy as a Method for Skin Cancer Risk Assessment
- Author
-
John K. Geisse, Michael A Bonning, Danielle Manolakos, Holly Christman, Ousama M. A'Amar, David J. Leffell, Eladio Rodriguez-Diaz, and Irving J. Bigio
- Subjects
Male ,medicine.medical_specialty ,Skin Neoplasms ,Malignancy ,Biochemistry ,Lesion ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,medicine ,Humans ,Physical and Theoretical Chemistry ,Skin ,business.industry ,Spectrum Analysis ,Melanoma ,General Medicine ,Middle Aged ,medicine.disease ,Clinical trial ,030220 oncology & carcinogenesis ,Female ,Radiology ,Skin cancer ,medicine.symptom ,Risk assessment ,Skin lesion ,business ,Skin preparation - Abstract
Skin cancer is the most prevalent cancer, and its assessment remains a challenge for physicians. This study reports the application of an optical sensing method, elastic scattering spectroscopy (ESS), coupled with a classifier that was developed with machine learning, to assist in the discrimination of skin lesions that are concerning for malignancy. The method requires no special skin preparation, is non-invasive, easy to administer with minimal training, and allows rapid lesion classification. This novel approach was tested for all common forms of skin cancer. ESS spectra from a total of 1307 lesions were analyzed in a multi-center, non-randomized clinical trial. The classification algorithm was developed on a 950-lesion training dataset, and its diagnostic performance was evaluated against a 357-lesion testing dataset that was independent of the training dataset. The observed sensitivity was 100% (14/14) for melanoma and 94% (105/112) for non-melanoma skin cancer. The overall observed specificity was 36% (84/231). ESS has potential, as an adjunctive assessment tool, to assist physicians to differentiate between common benign and malignant skin lesions.
- Published
- 2019
- Full Text
- View/download PDF